News from us and our partners

Tags

Topics

0 results

News
7 March, 2023
Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing
News
1 March, 2023
Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors
News
1 March, 2023
Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines
News
24 February, 2023
Acquisition of CinCor Pharma complete
News
22 February, 2023
Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)
News
22 February, 2023
Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
News
15 February, 2023
Elicit Plant validates on a large scale the performance of its BEST-a product for corn that reduces crops’ water consumption and addresses the challenges of climate change
News
7 February, 2023
Prometheus Materials secures multiple ASTM certifications, bringing initial production into full-swing
News
2 February, 2023
RefleXion receives FDA clearance for SCINTIX biology-guided radiotherapy; cutting-edge treatment applicable for early and late-stage cancers
News
1 February, 2023
Prof. Jacques Séguin, renowned inventor of CoreValve, joins Endoron Medical as Chairman of the Board
News
26 January, 2023
AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry
News
24 January, 2023
Amolyt Pharma signs research agreement and license option with XOMA
News
23 January, 2023
Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke
News
19 January, 2023
PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO
News
17 January, 2023
Shockwave Medical announces agreement to acquire Neovasc
Feature
16 January, 2023
For our team, investment is about impact

Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing

Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors

Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines

Acquisition of CinCor Pharma complete

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)

Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors

Elicit Plant validates on a large scale the performance of its BEST-a product for corn that reduces crops’ water consumption and addresses the challenges of climate change

Prometheus Materials secures multiple ASTM certifications, bringing initial production into full-swing

RefleXion receives FDA clearance for SCINTIX biology-guided radiotherapy; cutting-edge treatment applicable for early and late-stage cancers

Prof. Jacques Séguin, renowned inventor of CoreValve, joins Endoron Medical as Chairman of the Board

AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry

Amolyt Pharma signs research agreement and license option with XOMA

Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke

PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO

Shockwave Medical announces agreement to acquire Neovasc

For our team, investment is about impact